Form 4 Tracker
Tiago Girao

Chief Financial Officer · 3 filings · Latest: Jun 26, 2026

Immunovant, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
IMVT
Tiago GiraoChief Financial OfficerJun 26, 2026
Sale
$38.4610,000$384.6K247,596
IMVT
Tiago GiraoChief Financial OfficerJun 26, 2026
Option Exercise
$15.9010,000$159.0K257,596
IMVT
TIAGO GIRAOJun 26, 2026
Proposed Sale
$38.4610,000$384.6K
IMVT
Tiago GiraoChief Financial OfficerApr 23, 2026
Sale
$29.6225,760$763.0K247,596